Investments
3About Altman Health Investments
Altman Health Investments (AHI) is a seed fund focused on investments for the improvement of human health. AHI was founded by Greg Altman, PhD, and Rebecca Horan, PhD, long time business partners and co-founders of Silk Therapeutics.
Altman Health Investments Headquarter Location
United States
Latest Altman Health Investments News
Sep 28, 2017
Silk Therapeutics, Inc. , a Medford, Mass.-based specialty biomaterials company, closed an $11m Series A3 financing. The round was led by Jeff Vinik, the former manager of Fidelity’s Magellan Fund and owner of the Tampa Bay Lightning, and legacy investor, the Kraft Group, along with support from additional existing investors Roy P. Disney, Lear Corporation, and Altman Health Investments. The company intends to use the funds to continue to expand its development efforts. Led by Greg Altman, Chief Executive Officer, and Rebecca Lacouture, Chief Operating Officer, Silk Therapeutics provides clean and EWG VERIFIED™ skincare collections that feature pure, liquid silk as an active ingredient. After receiving five patent approvals in 2016, the company worked to build-out its new natural chemistry platform, which propelled the development of liquid silk at mass scale. After testing, Silk Therapeutics discovered use cases in fabric whereby liquid silk infused into the surface layer offers multiple benefits for the performance apparel industry. FinSMEs 20/09/2017
Altman Health Investments Investments
3 Investments
Altman Health Investments has made 3 investments. Their latest investment was in Silk Therapeutics as part of their Series A - IV on August 8, 2017.
Altman Health Investments Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/2/2017 | Series A - IV | Silk Therapeutics | $11M | No | 6 | |
2/3/2016 | Series A - III | |||||
5/5/2015 | Series A - II |
Date | 8/2/2017 | 2/3/2016 | 5/5/2015 |
|---|---|---|---|
Round | Series A - IV | Series A - III | Series A - II |
Company | Silk Therapeutics | ||
Amount | $11M | ||
New? | No | ||
Co-Investors | |||
Sources | 6 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.